COMPANY PROFILE · UPDATED 18 NOV 2025

Obsidian Therapeutics

Obsidian Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops adoptive cell therapies for the treatment of patient with cancer diseases. Obsidian Therapeutics serves customers in the State of…

obsidiantx.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2015
Headcount: 111
Open roles: 5
Last raised: Series C · Sign in to view

TECH STACK

How Obsidian Therapeutics builds

LEADERSHIP

Founders & key people

Michael Gilman

CTO at Qualex Consulting Services

Arrakis TherapeuticsScholar Rock HoldingObsidian TherapeuticsAtlas VenturePadlock TherapeuticsBiogenUniversity of California BerkeleyMassachusetts Institute of Technology (MIT)Taft High, Woodland Hills CA

Tariq Kassum

CEO at Celsius Therapeutics

Celsius TherapeuticsObsidian TherapeuticsAtlas VentureTakeda OncologyTakedaSeneca CapitalUniversity of TorontoCornell UniversityUpper Canada College

Steve Shamah

President from United States

Obsidian Therapeuticsbluebird bioJuno TherapeuticsX-Body BiosciencesSRU BiosystemsArchemix CorporationHarvard Medical SchoolUniversity of Rochester

OPEN ROLES

Hiring at Obsidian Therapeutics

FUNDING

Capital raised

Total raised

$325,000,000

Investors

GvAlexandria Venture InvestmentsAmgenAtlas VentureBlue OwlBristol-Myers Squibb CompanyCOWENDeep Track CapitalForesite CapitalHenderson Global InvestorsLogos CapitalNovo HoldingsParadigm BioCapital AdvisorsPivotal bioVenture PartnersRA Capital ManagementRTW InvestmentsSamsara BioCapitalShangPharmaSoleus CapitalSurveyor CapitalT. Rowe PriceTCGXTakeda VenturesThe Column GroupVertex PharmaceuticalsVertex VenturesVertex Ventures HCWellington ManagementWoodline Partners

Funding rounds

Series C
Wellington Management, Foresite Capital, RTW Investments, Novo Holdings, Henderson Global Investors, Woodline Partners, Atlas Venture, Paradigm BioCapital Advisors, Bristol-Myers Squibb Company, Samsara BioCapital, RA Capital Management, Blue Owl, Deep Track Capital, Surveyor Capital, Logos Capital, TCGX, T. Rowe Price
$160.5MApr 2, 2024
Series B
The Column Group, Pivotal bioVenture Partners, Soleus Capital, COWEN, Surveyor Capital, Samsara BioCapital, Deep Track Capital, Logos Capital, RA Capital Management, Atlas Venture, Bristol-Myers Squibb Company, Amgen, Vertex Ventures HC, TCGX
$115MSep 8, 2021
Series A
GV, Takeda Ventures, Atlas Venture, Amgen, ShangPharma, Alexandria Venture Investments, Vertex Ventures HC, Vertex Ventures, Vertex Pharmaceuticals
$49.5MDec 5, 2017

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Mysql Php Go Python Wordpress

LOCATIONS

Where they work

Obsidian Therapeutics Headquarters Location

1030 Massachusetts Avenue suite 400, Cambridge, MA, 02138

Loading map…